2015 IEEE International Conference on Rehabilitation Robotics (ICORR) 2015
DOI: 10.1109/icorr.2015.7281295
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of upper limb movement with an autonomous robotic device in a school environment for children with Cerebral Palsy

Abstract: Robotic devices are becoming more prevalent in rehabilitation of neurological disorders. Studies focus on clinical measures alongside robotic intervention, but assessment data can be collected as the subjects are using the rehabilitation device. As part of an autonomous robotic rehabilitation device in primary schools, this paper introduces an assessment tool that can engage subjects and measure performance on a more granular scale across an 8 week intervention. The deployments are split in to two parts of sin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 11 publications
0
4
0
Order By: Relevance
“…More specifically, in the first group, the NJIT-RAVR has been used to evaluate the hand movement speed, movement duration, smoothness and range of motion [67][68][69]; the WristBot and the reHaptic Handle have been used to quantify the maximum range of motion of the wrist [49,70,71]; the InMotion2 and REAPlan devices have been used to evaluate the straightness, speed and smoothness of trajectories in specific reaching activities [15,24]; and additionally, InMotion2 has also been used in a multi-joint planar task requiring coordination of the shoulder and elbow joint in order to assess the upper limb motor performance after injections of botulinum toxin type A (BTX-A) in children with hemiplegia due to CP or ABI [64]. Moreover, the MyPam robot has been used to evaluate motor performance in reaching tasks, demonstrating neurological enhancement through maintaining and improving motor skills in the washout period after robotic training in children with CP [50].…”
Section: Robotic Protocols For Upper Limb Assessmentmentioning
confidence: 99%
See 2 more Smart Citations
“…More specifically, in the first group, the NJIT-RAVR has been used to evaluate the hand movement speed, movement duration, smoothness and range of motion [67][68][69]; the WristBot and the reHaptic Handle have been used to quantify the maximum range of motion of the wrist [49,70,71]; the InMotion2 and REAPlan devices have been used to evaluate the straightness, speed and smoothness of trajectories in specific reaching activities [15,24]; and additionally, InMotion2 has also been used in a multi-joint planar task requiring coordination of the shoulder and elbow joint in order to assess the upper limb motor performance after injections of botulinum toxin type A (BTX-A) in children with hemiplegia due to CP or ABI [64]. Moreover, the MyPam robot has been used to evaluate motor performance in reaching tasks, demonstrating neurological enhancement through maintaining and improving motor skills in the washout period after robotic training in children with CP [50].…”
Section: Robotic Protocols For Upper Limb Assessmentmentioning
confidence: 99%
“…The color filling the circular areas indicates the number of clinical studies performed in the specific locations. The robot selected are:KINARM[46]; ACT3D[47]; NJIT-RAVR[48]; reHaptic Handle[49]; MyPam[50]; REAPlan[15]; ChARMin[51]; Armeo Spring[44]; PASCAL[52]; AMADEO[53]; WristBot[54]; InMotion2[45]; IOTA[55]; Novint Falcon[56].…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…During the testing, a humanoid robotic arm, ALAN [11], developed at the University of Leeds, was used to replicate the recorded arm movements of a representative stroke patient playing a rehabilitation game. The patient trajectory data utilized was collected during a trial of the MyPAM system, an active home-based rehabilitation robot also developed at the University of Leeds [12]. A sample data set was chosen belonging to an 81 year old female who was 132 days post-stroke at the time of recruitment to the aforementioned trial.…”
Section: Experimental Methodologymentioning
confidence: 99%